Search Results - "Wuolijoki, E"

Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial by Vendt, N, Grünberg, H, Tuure, T, Malminiemi, O, Wuolijoki, E, Tillmann, V, Sepp, E, Korpela, R

“…Probiotic bacteria have beneficial effects on the immune system and gastrointestinal tract, but the impacts of their long-term consumption on health and growth…”
Get full text

In vivo and in vitro degradation of a novel bioactive guided tissue regeneration membrane by Nieminen, T., Kallela, I., Keränen, J., Hiidenheimo, I., Kainulainen, H., Wuolijoki, E., Rantala, I.

“…The aim of this study was to assess degradation of a novel bioactive guided tissue regeneration (GTR) membrane and to quantify the concurrent tissue responses…”
Get full text

Decrease in serum LDL cholesterol with microcrystalline chitosan by WUOLIJOKI, E, HIRVELÄ, T, YLITALO, P

“…Peroral microcrystalline chitosan (MCCh; 3 capsules, each 400 mg b.i.d.) or placebo was given for 8 weeks in a double-blind manner to 51 healthy obese women…”
Get full text

Diclofenac and oxycodone in treatment of postoperative pain: a double-blind trial by Nuutinen, L S, Wuolijoki, E, Pentikäinen, I T

“…The effects of a prostaglandin synthesis inhibitor (diclofenac, Voltaren) and an opiate (oxycodone, Oxanest) on postoperative pain were compared. Included in…”
Get more information

Effective postoperative pain control by preoperative injection of diclofenac by WUOLIJOKI, E, OIKARINEN, V. J, YLIPAAVALNIEMI, P, HAMPF, G, TOLVANEN, M

“…We have treated ninety-five patients undergoing surgical removal of third molar with diclofenac or placebo, administered double-blind either pre- or…”
Get full text

Comparison of diclofenac and indomethacin suppositories in rheumatoid arthritis by Wafin, F, Valindas, E, Wuolijoki, E

“…The efficacy and tolerability of 100 mg suppositories of diclofenac sodium (Voltaren) and indomethacin were investigated in relieving symptoms of rheumatoid…”
Get full text

Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemia by Päivä, Hannu, Lehtimäki, Terho, Laakso, Juha, Ruokonen, Inkeri, Tervonen, Riitta, Metso, Saara, Nikkilä, Matti, Wuolijoki, Erkki, Laaksonen, Reijo

“…Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor that participates in the regulation of vasodilatory function and is also…”
Get full text

Treatment of primary dysmenorrhea with diclofenac sodium by Riihiluoma, P, Wuolijoki, E, Pulkkinen, M O

“…The efficacy of diclofenac sodium was investigated in the painful symptoms of primary dysmenorrhea and in reducing menstrual bleeding. Thirty-five nulliparous…”
Get more information

Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base by Wuolijoki, E, Flygare, U, Hildén, M, Hurme, J, Järvinen, H, Leskinen, J, Pynnönen, S, Riikonen, A, Salomaa, V, Seuri, M

“…Erythromycin acistrate (EA)--a new ester of erythromycin--was compared with erythromycin base as enterocoated pellets in capsules (EB enterocapsules) and…”
Get more information

Interleukin-6 Modulates Plasma Cholesterol and C-Reactive Protein Concentrations in Nonagenarians by Lehtimäki, Terho, Ojala, Petri, Rontu, Riikka, Goebeler, Sirkka, Karhunen, Pekka J., Jylhä, Marja, Mattila, Kari, Metso, Saara, Jokela, Hannu, Nikkilä, Matti, Wuolijoki, Erkki, Hervonen, Antti, Hurme, Mikko

“…Objectives: To establish whether the relationship between interleukin‐6 (IL‐6) and plasma lipid and C‐reactive protein (CRP) concentrations is different in…”
Get full text

Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non-carriers: a long-term placebo-controlled trial in hypercholesterolaemic volunteers by Lehtimäki, Terho, Metso, Saara, Ylitalo, Ritva, Rontu, Riikka, Nikkilä, Matti, Wuolijoki, Erkki, Ylitalo, Pauli

“…Chitosan is a deacetylated product of chitin. Microcrystalline form of chitosan has a large adsorption area claimed to decrease gastrointestinal absorption of…”
Get full text

The effect of long-term microcrystalline chitosan therapy on plasma lipids and glucose concentrations in subjects with increased plasma total cholesterol: a randomised placebo-controlled double-blind crossover trial in healthy men and women by METSO, Saara, YLITALO, Ritva, NIKKILÄ, Matti, WUOLIJOKI, Erkki, YLITALO, Pauli, LEHTIMÄKI, Terho

“…To evaluate the long-term effect of microcrystalline chitosan (MCC) on plasma lipids, especially the concentration of low-density lipoprotein (LDL)…”
Get full text

Decrease in serum LDL cholesterol with microcrystalline chitosan in healthy subjects by Lehtimäki, T., Wuolijoki, E., Hirvelä, T., Lehtinen, S., Ylitalo, R., Nousiainen, P., Ylitalo, P.

Get full text

Cholesterol-lowering Properties and Safety of Chitosan by Ylitalo, Ritva, Lehtinen, Saara, Wuolijoki, Erkki, Ylitalo, Pauli, Lehtimäki, Terho

“…Summary Chitosan (CAS 9012-76-4) is derived by alkaline deacetylation from chitin, an abundant polymeric product of natural biosynthesis especially in…”
Get full text

Relief of spasm with diclofenac by Flygare, U, Seuri, M, Hurme, J, Wuolijoki, E

Get full text

Treatment of juvenile rheumatoid arthritis with diclofenac sodium by Haapasaari, J, Wuolijoki, E, Ylijoki, H

“…Diclofenac sodium was investigated in the treatment of juvenile rheumatoid arthritis (JRA). The pharmacokinetics of diclofenac in children aged 2-7 was…”
Get more information